TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Daily living ability (ADL scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from atrial tachyarrhythmia
Endpoint domain: Mortality/survival
Primary endpoint: Primary kidney outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increasing tobacco consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-BACK accuracy rate improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in CPRS‐R‐L and CBCL total T scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved focus attention (target accuracy rate and omission errors)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower perseverative and non‐perseverative errors in WCST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total prostate cancer-specific anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: One-Year Overall Survival
Endpoint domain: Mortality/survival
Primary endpoint: Cerebral hemoglobin oxygenation (∆[HbO])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral oxidized cytochrome c oxidase (∆[oxi‐CCO])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sit and Reach test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: non-COVID illnesses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detrusor pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients with HbA1c less than 7.0% without SHE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Behavioral responses of pain and crying duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic safety (CTCAE Grade increases in ALT or AST)
Endpoint domain: Adverse events/effects
Primary endpoint: Coefficient of Variation (CV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hexagonal Cell Percentage (%HEX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS‐UPDRS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADCS‐CGIC scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Facial pigment intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Median duration from hospitalization to virus nucleic acid negative conservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time for body temperature normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiological progression shown on CT images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of COVID-19 as a dirty or shameful disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Importance of keeping COVID-19 infection a secret
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rapid Weight Gain (RWG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overweight (OW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of medications for treating pain in women with VBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilateral lower muscle symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: definitely positive behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Body weight and fat mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Height improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pliability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vascularity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean T@0.2 s for knee flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean T@0.2 s for knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean anaerobic power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: immediate EVM improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: delayed EVM improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: non-healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful decongestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death from any cause or rehospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: parental warmth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: setting limits
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: proactive parenting
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Risk for stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk for major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Cutaneous Dermatomyositis Disease Area and Severity Index activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: submaximal heart rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in BSP at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in BSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient activation
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: SoC
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: high-quality embryo rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: transplantable embryo rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Distance in standing shot put
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the UCLA Loneliness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement on the Personal Health Questionnaire for Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement on the Generalized Anxiety Disorder scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative refractive astigmatism of ≤0.5 D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean net corneal changes along the CRI meridian
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative astigmatism vector prediction errors of ≤0.50 D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDL subclass profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Enrollment rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Need for further ecbolics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Device-oriented endpoint rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-oriented composite endpoint rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative hemoglobin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of hybrid fibroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of life improvement (SIBDQ scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life improvement (EuroQol 5 D‐3L scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall satisfaction with MaMICI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiovascular death/HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Grade 3/4 Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain measured by FLACC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stigma related to PrEP use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decentration value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tilt value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptable pain at 4-mm depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal needle-insertion depths with acceptable pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anesthetic effect duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of how to make child's food nutrient and energy dense
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: awareness of at least two modern spacing family planning methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: egg consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of nerve blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of all 4 nerves blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time of nerve blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: A2M protease levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: students' self-reported experience of physical violence from teachers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome diversity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Biochemically-verified 7-day point prevalence abstinence at 26 weeks post-quit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical performance of deep restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QIDS-SR score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diminished requirement for prokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fewer oropharyngeal aspirations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decreased gastric residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: K10 change score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional impairment in home and work/school activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: planning accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip joint extension angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of the rectus femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean square root area of MA progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative rescue doses of analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NRS pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days alive without life support
Endpoint domain: Mortality/survival
Primary endpoint: mortality at Day 90
Endpoint domain: Mortality/survival
Primary endpoint: Risk of overweight/obesity at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body mass index at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total allergy risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CPSP (Chronic Post-Surgical Pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEP CV (Motor Evoked Potential Coefficient of Variation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blunt thoracic aortic injury risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of infusion-related reactions (IRRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of infusion-related reactions (IRRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Radiation dermatitis grade 2/3
Endpoint domain: Adverse events/effects
Primary endpoint: Breast/chest wall pain
Endpoint domain: Adverse events/effects
Primary endpoint: incongruent reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reverse Stroop interference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adjusted death/myocardial infarction/unstable angina hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: composite primary outcome event rate
Endpoint domain: Mortality/survival
Primary endpoint: Disgust ratings for the maggot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative nausea and dizziness
Endpoint domain: Adverse events/effects
Primary endpoint: plasma circDYM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scores of the 24‐item Hamilton Depression Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of alcohol-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cosmetic score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in GGT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Rim arterial phase hyperenhancement proportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of analgesic demands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first demand for analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of color change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported SR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported SP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incident delirium
Endpoint domain: Adverse events/effects
Primary endpoint: modulation of the amplitude of the beta rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fat Mass (FM) Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viscoelastic properties of soft-tissue fillers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-acetyl-β-d-glucosaminidase/creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: β2-microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in caregiver strain
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Nursing knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lost follow-up rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-operative defaecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean D15 NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGIC score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Chronic hypnotic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labor pain VAS-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in BBPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: humeral head motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of gingivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete fusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: JOA-BPEQ and VAS scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HIV care coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ART coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SANS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability-Adjusted Life Years (DALYs) averted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of training interventions on UDD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of mistakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensory reactivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repetitive behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in length-for-age z scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Experience (OTU)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: kaolin TEG r-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal endotracheal tube placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excessive weight gain during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak force during the isometric squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jump height in CMJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak power in CMJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of the role of clinical pharmacists
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in minimizing medication errors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to cooperate with clinical pharmacists
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Suturing quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life as measured by CFQ-R
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dentin loss during post removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: session-RPE TL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in Executive Function (EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Occupational Performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Median fruit intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of taking folic acid supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breaths within diaphragm-protective range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WBFPRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEM scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes